[Federal Register: February 27, 2009 (Volume 74, Number 38)]
[Notices]
[Page 9018-9019]
[DOCID:fr27fe09-133]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Railroad Administration

Petition for Waiver of Compliance

    In accordance with Part 211 of Title 49 Code of Federal Regulations
(CFR), notice is hereby given that the Federal Railroad Administration
(FRA) has received a request for a waiver of compliance from certain
requirements of its safety standards. The individual petition is
described below, including the party seeking relief, the regulatory
provisions involved, the nature of the relief being requested, and the
petitioner's arguments in favor of relief.

Maryland Department of Transportation

[Waiver Petition Docket Number FRA-2009-0010]

    The Maryland Department of Transportation (MTA) seeks a permanent
waiver of compliance from 49 CFR 213.245 Vehicle Qualification Testing,
as part of its recent purchase of new model MP36PH-3C locomotives for
operation by its MARC train service on the National Passenger Railroad
Corporation's (Amtrak) Northeast Corridor (NEC) at 100 miles per hour
(mph) and three inches cant deficiency.
    MTA would like the FRA to allow qualification of these locomotives
to occur without using the instrumented wheel-sets (IWS) test specified
in Sec.  213.245. MTA has stated that this test is costly and not
economically justified, given the long service history of the same
truck that is currently in operation with similar locomotives. MTA
further explains that the truck used on the MP36PH-3C locomotive has an
extensive history of service on the Amtrak NEC with MARC GP39 and GP40
locomotives, and have been successfully tested to 110 mph.
    MP36PH-3C's are used by Caltrain, MRCOG, UTA, and SCRRA, although
not at FRA Class 6 speeds. MTA argues that the MP36PH-3C locomotive has
similar carbody, weight, truck assemblies, and wheel profile as the GO
Transit (Toronto) MP40PH-3C locomotive, which has been successfully
tested at the Transportation Technology Center, Inc (TTCI) for safe
operation up to 103 mph. The MP40PH-3C was approved by Transport Canada
and Canadian National Railroad (CN). An important factor here is that
in lieu of IWS, TTCI measured wheel/rail forces estimated by NUCARS
simulations modeling software and by using wayside measuring systems
such as strain gauges on instrumented rails.
    MTA proposes to qualify these locomotives on the Amtrak NEC at
speeds up to 112 mph by monitoring truck frame lateral accelerations at
positions above each of the four axles; and both vertical and lateral
accelerations of the carbody on the cab floor and on the floor at the
rear end of the locomotive. These will be evaluated against the 49 CFR
213.333 Vehicle Track Interaction Limits. MTA will have NUCARS
simulations performed by TTCI for the specific parameters to evaluate
wheel-rail forces for speeds and track geometry of the MARC route over
the Amtrak NEC.
    Interested parties are invited to participate in these proceedings
by submitting written views, data, or comments. FRA does not anticipate
scheduling a public hearing in connection with these proceedings since
the facts do not appear to warrant a hearing. If any interested party
desires an opportunity for oral comment, they should notify FRA, in
writing, before the end of the comment period and specify the basis for
their request.
    All communications concerning these proceedings should identify the
appropriate docket number (e.g., Waiver Petition Docket Number FRA-
2009-0010) and may be submitted by any of the following methods:
     Web site: http://www.regulations.gov. Follow the online
instructions for submitting comments.
     Fax:<PHONE_NUMBER>.
     Mail: Docket Operations Facility, U.S. Department of
Transportation, 1200 New Jersey Avenue, SE., W12-140, Washington, DC
20590.
     Hand Delivery: 1200 New Jersey Avenue, SE., Room W12-140,
Washington, DC 20590, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays.
    Communications received within 45 days of the date of this notice
will be considered by FRA before final action is taken. Comments
received after that date will be considered as far as practicable. All
written communications concerning these proceedings are available for
examination during regular business hours (9 a.m.-5 p.m.) at the above
facility. All documents in the public docket are also available for
inspection and copying on the Internet at the docket facility's Web
site at http://www.regulations.gov.
    Anyone is able to search the electronic form of any written
communications and comments received into any of our dockets by the
name of the individual submitting the comment (or signing the comment,
if submitted on behalf of an association, business, labor union, etc.).
You may

review DOT's complete Privacy Act Statement in the Federal Register
published on April 11, 2000 (Volume 65, Number 70; Pages 19477-78).

    Issued in Washington, DC on February 23, 2009.
Grady C. Cothen, Jr.,
Deputy Associate Administrator for Safety Standards and Program
Development.
[FR Doc. E9-4207 Filed 2-26-09; 8:45 am]

BILLING CODE 4910-06-P


[Federal Register: March 27, 2009 (Volume 74, Number 58)]
[Notices]
[Page 13427]
[DOCID:fr27mr09-43]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL09-42-000]

Dartmouth Power Associates, Limited Partnership, Complainant v.
ISO New England Inc., Respondent; Notice of Complaint

March 20, 2009.
    Take notice that on March 20, 2009, pursuant to section 206 of the
Rules and Practice and Procedure, 18 CFR 385.206, Dartmouth Power
Associates Limited Partnership (Complainant) filed a formal complaint
against ISO New England Inc. (Respondent) as an appeal of the
Respondent's denial of Complainant's Requested Billing Adjustment on
February 20, 2009, which relates to the Respondent's revocation of
Complainant's June 2008 Installed Capacity Payments.
    The Complainant certifies that a copy of the complaint has been
served on the Respondent.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. The Respondent's
answer and all interventions, or protests must be filed on or before
the comment date. The Respondent's answer, motions to intervene, and
protests must be served on the Complainants.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://
www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on April 9, 2009.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-6868 Filed 3-26-09; 8:45 am]


[Federal Register Volume 79, Number 19 (Wednesday, January 29, 2014)]
[Notices]
[Pages 4688-4689]
[FR Doc No: 2014-01665]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2013-0287; FRL-9905-86-OEI]

Information Collection Request Submitted to OMB for Review and
Approval; Comment Request; Pesticide Registration Fees Program

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: EPA has submitted the following Information Collection Request
(ICR) to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act: ``Pesticide
Registration Fees Program'' (EPA ICR No. 2330.02, OMB Control No. 2070-
0179). This is a request to renew an existing collection. The ICR,
which is abstracted below, describes the nature of the information
collection activity and its expected burden and costs. Copies of the
ICR and related documents are available in the docket.

DATES: Additional comments may be submitted on or before February 28,
2014.

ADDRESSES: Submit your comments, referencing Docket ID Number EPA-HQ-
OPP-2013-0287, to (1) EPA online using www.regulations.gov (our
preferred method), or by mail to: EPA Docket Center, Environmental
Protection Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW.,
Washington, DC 20460, and (2) OMB via email to<EMAIL_ADDRESS>Address comments to OMB Desk Officer for EPA.
    EPA's policy is that all comments received will be included in the
public docket without change including any personal information
provided, unless the comment includes profanity, threats, information
claimed to be Confidential Business Information (CBI) or other
information whose disclosure is restricted by statute.
    The docket can be viewed online at www.regulations.gov or in person
at the EPA Docket Center, WJC West, Room 3334, 1301 Constitution Ave.
NW., Washington, DC. The telephone number for the Docket Center is 202-
566-1744. For additional information about EPA's public docket, visit
http://www.epa.gov/dockets.

FOR FURTHER INFORMATION CONTACT: Cameo G. Smoot, Field and External
Affairs Division (7506P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave. NW., Washington, DC 20460;

telephone number:<PHONE_NUMBER>; fax number:<PHONE_NUMBER>; email
address: smoot.cameo @epa.gov.

SUPPLEMENTARY INFORMATION: EPA submitted the following ICR to OMB for
review and approval in accordance with the Paperwork Reduction Act (44
U.S.C. 3501 et seq.), and the procedures in 5 CFR 1320.12. Prior Public
Notice: Pursuant to 5 CFR 1320.8(d), EPA announced and provided a 60-
day public comment period on the information collection activities as
described in this ICR (78 FR 36774, June 19, 2013). EPA received two
public comments which are posted in the docket EPA-HQ-OPP-2013-0287 for
this action. This notice allows for an additional 30 days for public
comments.
    ICR Status: This is a renewal for a currently approved ICR. This
ICR is currently scheduled to expire on February 28, 2014. Under the
PRA, an Agency may not conduct or sponsor and a person is not required
to respond to a collection of information unless it displays a
currently valid OMB control number. The OMB control numbers for EPA's
regulations in title 40 of the CFR, after appearing in the Federal
Register, are listed in 40 CFR part 9 and are included on the related
collection instrument or form, if applicable.
    Abstract: Pesticide registrants are required by statute to pay an
annual registration maintenance fee for all products registered under
Section 3 and Section 24(c) of the Federal Insecticide, Fungicide and
Rodenticide Act (FIFRA). In addition, the Pesticide Registration
Improvement Act (PRIA) amended FIFRA in 2004 to create a registration
service fee system for applications for specific pesticide
registration, amended registration, and associated tolerance actions
(Section 33). This ICR specifically covers the activities related to
the collection of the annual registration maintenance fees, the
registration service fees and the burden associated with the submission
of requests for fees to be waived.
    Form Numbers: EPA Form 8570-30--Pesticide Registration Fee Filing
Form.
    Respondents/affected entities: Entities potentially affected by
this ICR are pesticide and other agricultural chemical manufacturers,
other basic inorganic chemical manufacturers, other basic organic
chemical manufacturers, and regulators of agricultural marketing
commodities.
    Respondent's obligation to respond: Responses to this collection of
information are required to obtain or retain a benefit (i.e.,
registration of a pesticide).
    Estimated number of respondents: 1744
    Frequency of response: Annual and on occasion.
    Total estimated annual burden: 7,907 hours. Burden is defined at 5
CFR 1320.3(b).
    Total estimated annual cost: $535,728 For both programs.
    Changes in the Estimates: The total annual respondent burden
increased by 342 hours for the Pesticide Product Maintenance fees
program and also increased 303 hours for the Pesticide Registration
Service Fee waivers compared with that identified in the ICR currently
approved by OMB. This increase reflects a slight increase in the number
of requests submitted to the agency. This change is an adjustment.

John Moses,
Director, Collection Strategies Division.
[FR Doc. 2014-01665 Filed 1-28-14; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 84, Number 102 (Tuesday, May 28, 2019)]
[Notices]
[Pages 24530-24531]
[FR Doc No: 2019-11057]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Coast Guard

[Docket No. USCG-2019-0254]

Commercial Fishing Safety Advisory Committee

AGENCY: U.S. Coast Guard, Department of Homeland Security.

ACTION: Request for applications.

-----------------------------------------------------------------------

SUMMARY: The U.S. Coast Guard seeks applications for membership on the
Commercial Fishing Safety Advisory Committee. The Commercial Fishing
Safety Advisory Committee provides advice and makes recommendations to
the Coast Guard and the Department of Homeland Security on various
matters relating to the safe operation of commercial fishing industry
vessels.

DATES: Completed applications should reach the U.S. Coast Guard on or
before July 29, 2019.

ADDRESSES: Applicants should send a cover letter expressing interest in
an appointment to the Commercial Fishing Safety Advisory Committee and
a resume detailing the applicant's experience. We will not accept a
biography. Incomplete applications will not be considered. The cover
letter and/or resume should include the following:
     Membership category the applicant is seeking an
appointment for;
     Your home address, phone number and email address;
     Your employer's name and address (if applicable); and
     Your work phone number and email address (if applicable).
    Applications should be submitted via one of the following methods:
     By Email<EMAIL_ADDRESS>    Subject line: The Commercial Fishing Safety Advisory Committee
(preferred).
     By Mail: Commandant (CG-CVC-3)/CFSAC, Attn: Mr. Jonathan
Wendland, U.S. Coast Guard, 2703 Martin Luther King Ave. SE, Stop 7501,
Washington, DC 20593-7501.

FOR FURTHER INFORMATION CONTACT: Mr. Jonathan Wendland, Alternate
Designated Federal Officer of the Commercial Fishing Safety Advisory
Committee,<PHONE_NUMBER> or<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: The Commercial Fishing Safety Advisory
Committee is a federal advisory committee which operates under the
provisions of the Federal Advisory Committee Act, (Title 5, U.S.C.
Appendix 2). The U.S. Coast Guard chartered the Commercial Fishing
Safety Advisory Committee to provide advice on issues related to the
safety of commercial fishing industry vessels regulated under Chapter
45 of title 46, United States Code, which includes uninspected fish
catching vessels, fish processing vessels, and fish tender vessels.
(See Title 46 U.S.C. 15102)
    The Commercial Fishing Safety Advisory Committee meets at least
once a year. It may also meet for other extraordinary purposes. Its
subcommittees or working groups may communicate throughout the year to
prepare for meetings or develop proposals for the committee as a whole
or to address specific tasks.
    Each member serves for a term of three years. An individual may be
appointed to a term as a member more than once, but not more than two
terms consecutively. All members serve at their own expense and receive
no salary or other compensation from the Federal Government, although
travel reimbursement and per diem may be provided for called meetings.
    The U.S. Coast Guard will consider applications for seven positions
that will be vacant on June 2019 in the following categories:
    (a) Individuals who represent the Commercial Fishing Industry(five
Positions);
    (b) Naval Architect/Marine Engineer (one position);
    (c) An individual who represents the general public, a person
familiar with issues affecting fishing communities and families of
fishermen (one position).
    If you are selected as a member from the general public (c above),
you will be appointed and serve as a Special Government Employee as
defined in Section 202(a) of Title 18, U.S.C. Applicants for
appointment as a Special Government Employee are required to complete a
New Entrant Confidential Financial Disclosure Report (OGE Form 450)
prior to appointment and each year they serve thereafter. The U.S.
Coast Guard may not release the reports or the information in them to
the public except under an order issued by a Federal court or as
otherwise provided under the Privacy Act (5 U.S.C. 552a). Only the
Designated U.S. Coast Guard Ethics Official or his or her designee may
release a Confidential Financial Disclosure Report. Applicants can
obtain this form by going to the website of the Office of Government
Ethics (www.oge.gov), or by contacting the individual listed in FOR
FURTHER INFORMATION CONTACT.
    Registered lobbyists are not eligible to serve on federal advisory
committees in an individual capacity. See ``Revised Guidance on
Appointment of Lobbyist to Federal Advisory Committees, Boards, and
Commissions'' (79 CFR 47482, August 13, 2014). Registered lobbyists are
lobbyists as defined in Title 2, U.S.C. 1602 who are required by Title
2 U.S.C. 1603 to register with the Secretary of the Senate and the
Clerk of the House of Representatives. The position we list for a
member from the general public would be someone appointed in their
individual capacity and would be designated as a Special Government
Employee as defined in Section 202(a), Title 18, U.S.C.
    The Department of Homeland Security does not discriminate in
selection of Committee members on the basis of race, color, religion,
sex, national origin, political affiliation, sexual orientation, gender
identity, marital status, disability and genetic information, age,
membership in an employee organization, or any other non-merit factor.
The Department of Homeland Security strives to achieve a widely diverse
candidate pool for all of its recruitment actions.

    If you are interested in applying to become a member of the
Committee, send your cover letter and resume to Mr. Jonathan Wendland,
Commercial Fishing Safety Advisory Committee Alternate Designated
Federal Officer, via one of the transmittal methods in the ADDRESSES
section by the deadline in the DATES section. All email submittals will
receive an email receipt confirmation.

    Dated: May 22, 2019.
Jennifer F. Williams,
Captain, U.S. Coast Guard, Director of Inspections and Compliance.
[FR Doc. 2019-11057 Filed 5-24-19; 8:45 am]
BILLING CODE 9110-04-P


[Federal Register Volume 77, Number 9 (Friday, January 13, 2012)]
[Notices]
[Pages 2070-2071]
[FR Doc No: 2012-542]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0589]

Anneri Izurieta: Debarment Order

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is issuing an order
under the Federal Food, Drug, and Cosmetic Act (the FD&C Act) debarring
Anneri Izurieta for a period of 30 years from importing articles of
food or offering such articles for importation into the United States.
FDA bases this order on a finding that Ms. Izurieta was convicted of
six felony counts under Federal law for conduct relating to the
importation into the United States of an article of food. Ms. Izurieta
was given notice of the proposed debarment and an opportunity to
request a hearing within the timeframe prescribed by regulation. As of
November 4, 2011 (30 days after receipt of the notice), Ms. Izurieta
had not responded. Ms. Izurieta's failure to respond constitutes a
waiver of her right to a hearing concerning this action.

DATES: This order is effective January 13, 2012.

ADDRESSES: Submit applications for termination of debarment to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT:
    Kenny Shade, Office of Regulatory Affairs, Food and Drug
Administration, 12420 Parklawn Dr., Rockville, MD 20857, (301) 796-
4640.

SUPPLEMENTARY INFORMATION:

I. Background

    Section 306(b)(1)(C) of the FD&C Act (21 U.S.C. 335a(b)(1)(C))
permits FDA to debar an individual from importing an article of food or
offering such an article for import into the United States if FDA
finds, as required by section 306(b)(3)(A) of the FD&C Act, that the
individual has been convicted of a felony for conduct relating to the
importation into the United States of any food.
    On May 11, 2011, in the U.S. District Court for the Southern
District of Florida, Ms. Izurieta was convicted of one count of
conspiracy to smuggle goods into the United States, in violation of 18
U.S.C. 371, and five counts of smuggling goods into the United States,
in violation of 18 U.S.C. 545. The U.S. District Court for the Southern
District of Florida entered judgment against Ms. Izurieta on July 29,
2011.
    FDA's finding that debarment is appropriate is based on the felony
convictions referenced herein for conduct relating to the importation
into the United States of any food. The factual basis for these
convictions is as follows: On or about April 18, 2007, and continuing
through on or about December 23, 2010, in violation of 18 U.S.C. 371,
Ms. Izurieta knowingly, and with the intent to further the object of
the conspiracy, conspired with others to commit an offense against the
United States to fraudulently and knowingly import and bring into the
United States merchandise contrary to law in violation of 18 U.S.C.
545. Specifically, Ms. Izurieta conspired to distribute and sell
imported dairy products that FDA had detained after receiving notice
from FDA that the dairy products were suspected to be adulterated.
    While serving as president and director of Naver Trading, Ms.
Izurieta caused dairy products and other food to be imported from
Honduras and Nicaragua. Despite a request from FDA to disclose the
location of shipments of dairy products after learning that FDA had
slated specific shipments for examination due to concerns of
adulteration with Escherichia coli,

Staphylococcus aureus, and Salmonella, Ms. Izurieta failed to do so.
Ms. Izurieta also distributed shipments of dairy products after
learning that FDA had slated specific shipments for examination due to
concerns of adulteration with E. coli, S. aureus, and Salmonella. Ms.
Izurieta failed to redeliver for destruction and exportation shipments
of dairy products that FDA had determined to be adulterated with E.
coli, S. aureus, and Salmonella and that were not authorized for entry
into the United States. Ms. Izurieta then distributed dairy products
that were adulterated and not authorized for entry into the United
States. This conduct was in violation of 18 U.S.C. 545.
    From approximately April 18, 2007, and continuing to approximately
December 7, 2010, Ms. Izurieta fraudulently and knowingly imported and
brought into the United States merchandise contrary to law. Further,
Ms. Izurieta failed to redeliver, export, and destroy with FDA
supervision the dairy products and other food products contained in
these shipments after receiving notice from FDA regarding concerns
about the adulteration of these products with E. coli, S. aureus, and/
or Salmonella.
    As a result of her conviction, on September 28, 2011, FDA sent Ms.
Izurieta a notice by certified mail proposing to debar her for a period
of 30 years from importing articles of food or offering such articles
for import into the United States. The proposal was based on a finding
under section 306(b)(1)(C) of the FD&C Act that Ms. Izurieta was
convicted of six felony counts under Federal law for conduct relating
to the importation into the United States of an article of food because
she conspired to and did commit offenses related to the importation of
dairy products and other products into the United States, and a
determination, after consideration of the factors set forth in section
306(c)(3) of the FD&C Act that Ms. Izurieta should be subject to the
maximum possible period of debarment. The proposal also offered Ms.
Izurieta an opportunity to request a hearing, providing her 30 days
from the date of receipt of the letter in which to file the request,
and advised her that failure to request a hearing constituted a waiver
of the opportunity for a hearing and of any contentions concerning this
action. Ms. Izurieta failed to respond within the timeframe prescribed
by regulation and has, therefore, waived her opportunity for a hearing
and waived any contentions concerning her debarment (21 CFR part 12).

II. Findings and Order

    Therefore, the Director, Office of Enforcement, Office of
Regulatory Affairs, under section 306(b)(1)(C) of the FD&C Act, and
under authority delegated to the Director (Staff Manual Guide 1410.35),
finds that Ms. Anneri Izurieta has been convicted of six felony counts
under Federal law for conduct relating to the importation of an article
of food into the United States and that she is subject to the full
period of debarment.
    As a result of the foregoing finding, Ms. Izurieta is debarred for
a period of 30 years from importing articles of food or offering such
articles for import into the United States, effective (see DATES).
Under section 301(cc) of the FD&C Act (21 U.S.C. 331(cc)), the
importing or offering for import into the United States of an article
of food by, with the assistance of, or at the direction of Ms. Izurieta
is a prohibited act.
    Any application by Ms. Izurieta for termination of debarment under
section 306(d)(1) of the FD&C Act should be identified with Docket No.
FDA-2011-N-0589 and sent to the Division of Dockets Management (see
ADDRESSES). All such submissions are to be filed in four copies. The
public availability of information in these submissions is governed by
21 CFR 10.20(j).
    Publicly available submissions may be seen in the Division of
Dockets Management between 9 a.m. and 4 p.m., Monday through Friday.

    Dated: January 4, 2012.
Armando Zamora,
Acting Director, Office of Enforcement, Office of Regulatory Affairs.
[FR Doc. 2012-542 Filed 1-12-12; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 87, Number 216 (Wednesday, November 9, 2022)]
[Notices]
[Pages 67717-67718]
[FR Doc No: 2022-24445]

-----------------------------------------------------------------------

DEPARTMENT OF LABOR

Occupational Safety and Health Administration

[Docket No. OSHA-2010-0037]

Standard for Welding, Cutting, and Brazing; Extension of the
Office of Management and Budget's (OMB) Approval of Information
Collection (Paperwork) Requirements

AGENCY: Occupational Safety and Health Administration (OSHA), Labor.

ACTION: Request for public comments.

-----------------------------------------------------------------------

SUMMARY: OSHA solicits public comments concerning the proposal to
extend the Office of Management and Budget's (OMB) approval of the
information collection requirements specified in the Standard for
Welding, Cutting, and Brazing.

DATES: Comments must be submitted (postmarked, sent, or received) by
January 9, 2023.

ADDRESSES:
    Electronically: You may submit comments and attachments
electronically at http://www.regulations.gov, which is the Federal
eRulemaking Portal. Follow the instructions online for submitting
comments.
    Docket: To read or download comments or other material in the
docket, go to http://www.regulations.gov. Documents in the docket are
listed in the http://www.regulations.gov index; however, some
information (e.g., copyrighted material) is not publicly available to
read or download through the website. All submissions, including
copyrighted material, are available for inspection through the OSHA
Docket Office. Contact the OSHA Docket Office at<PHONE_NUMBER>, (TTY
(877) 889-5627) for assistance in locating docket submissions.
    Instructions: All submissions must include the agency name and OSHA
docket number (OSHA-2010-0037) for the Information Collection Request
(ICR). OSHA will place all comments, including any personal
information, in the public docket, which may be made available online.
Therefore, OSHA cautions interested parties about submitting personal
information such as social security numbers and birthdates. For further
information on submitting comments, see the ``Public Participation''
heading in the section of this notice titled SUPPLEMENTARY INFORMATION.

FOR FURTHER INFORMATION CONTACT: Seleda Perryman or Theda Kenney,
Directorate of Standards and Guidance, OSHA, U.S. Department of Labor;
telephone<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    The Department of Labor, as part of the continuing effort to reduce
paperwork and respondent (i.e., employer) burden, conducts a
preclearance consultation program to provide the public with an
opportunity to comment on proposed and continuing information
collection requirements in accordance with the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3506(c)(2)(A)). This program ensures that
information is in the desired format, reporting burden (time and costs)
is minimal, the collection instruments are clearly understood, and
OSHA's estimate of the information collection burden is accurate. The
Occupational Safety and Health Act of 1970 (OSH Act) (29 U.S.C. 651 et
seq.) authorizes information collection by employers as necessary or
appropriate for enforcement of the OSH Act or for developing
information regarding the causes and prevention of occupational
injuries, illnesses, and accidents (29 U.S.C. 657). The OSH Act also
requires that OSHA obtain such information with minimum burden upon
employers, especially those operating small businesses, and to reduce
to the maximum extent feasible unnecessary duplication of effort in
obtaining information (29 U.S.C. 657).
    The following sections describe who uses the information collected
under each requirement, as well as how they use it. The purpose of
these requirements is to reduce employees' risk of death or serious
injury by ensuring that employment has been tested and is in safe
operating condition.
    Section 1910.255(e) requires that a periodic inspection of
resistance welding equipment be made by qualified maintenance
personnel, and that a certification record be generated and maintained.
The certification shall include the date of the inspection, the
signature of the person who performed the inspection and the serial
number, or other identifier, for the equipment inspected. The record
shall be made available to an OSHA inspector upon request. The
maintenance inspection ensures that welding equipment is in safe
operating condition while the maintenance record provides evidence to
workers and agency compliance officers that employers performed the
required inspections.

II. Special Issues for Comment

    OSHA has a particular interest in comments on the following issues:
     Whether the proposed information collection requirements
are necessary for the proper performance of the agency's functions to
protect workers, including whether the information is useful;
     The accuracy of OSHA's estimate of the burden (time and
costs) of the information collection requirements, including the
validity of the methodology and assumptions used;
     The quality, utility, and clarity of the information
collected; and
     Ways to minimize the burden on employers who must comply;
for example, by using automated or other technological information
collection, and transmission techniques.

III. Proposed Actions

    The agency requests an adjustment decrease of 187 burden hours
(from 5,806 burden hours to 5,619 burden hours) associated with the
collections of information in the Welding, Cutting, and Brazing
Standard. This adjustment decrease is a result of a decrease in the
number of welders, cutters, solders, and brazers in general industry
from 21,770 to 21,070 a difference of 700 welders, cutter, solders, and
brazers in the previous package. The agency will summarize any comments
submitted in response to this notice and will include this summary in
its request to OMB.
    OSHA will summarize the comments submitted in response to this
notice and will include this summary in the request to OMB to extend
the approval of the information collection requirements.
    Type of Review: Extension of a currently approved collection.
    Title: The Standard for Welding, Cutting, and Brazing (29 CFR part
1910, subpart Q).
    OMB Control Number: 1218-0207.
    Affected Public: Business or other for-profits.

    Number of Respondents: 21,070.
    Number of Responses: 84,280.
    Frequency of Responses: On occasion.
    Average Time per Response: Varies.
    Estimated Total Burden Hours: 5,619.
    Estimated Cost (Operation and Maintenance): $0.

IV. Public Participation--Submission of Comments on This Notice and
Internet Access to Comments and Submissions

    You may submit comments in response to this document as follows:
(1) electronically at http://www.regulations.gov, which is the Federal
eRulemaking Portal; (2) by facsimile (fax); or (3) by hard copy. Please
note: While OSHA's Docket Office is continuing to accept and process
submissions by regular mail due to the COVID-19 pandemic, the Docket
Office is closed to the public and not able to receive submissions to
the docket by hand, express mail, messenger, and courier service. All
comments, attachments, and other material must identify the agency name
and the OSHA docket number for the ICR (Docket No. OSHA-2010-0037). You
may supplement electronic submissions by uploading document files
electronically. If you wish to mail additional materials in reference
to an electronic or a facsimile submission, you must submit them to the
OSHA Docket Office (see the section of this notice titled ADDRESSES).
The additional materials must clearly identify your electronic comments
by your name, date, and the docket number so that the agency can attach
them to your comments.
    Due to security procedures, the use of regular mail may cause a
significant delay in the receipt of comments.
    Comments and submissions are posted without change at http://www.regulations.gov. Therefore, OSHA cautions commenters about
submitting personal information such as social security numbers and
dates of birth. Although all submissions are listed in the http://www.regulations.gov index, some information (e.g., copyrighted
material) is not publicly available to read or download from this
website. All submissions, including copyrighted material, are available
for inspection and copying at the OSHA Docket Office. Information on
using the http://www.regulations.gov website to submit comments and
access the docket is available at the website's ``User Tips'' link.
Contact the OSHA Docket Office at<PHONE_NUMBER>, (TTY<PHONE_NUMBER>)
for information about materials not available from the website, and for
assistance in using the internet to locate docket submissions.

V. Authority and Signature

    James S. Frederick, Deputy Assistant Secretary of Labor for
Occupational Safety and Health, directed the preparation of this
notice. The authority for this notice is the Paperwork Reduction Act of
1995 (44 U.S.C. 3506 et seq.) and Secretary of Labor's Order No. 8-2020
(85 FR 58393).

James S. Frederick,
Deputy Assistant Secretary of Labor for Occupational Safety and Health.
[FR Doc. 2022-24445 Filed 11-8-22; 8:45 am]
BILLING CODE 4510-26-P


[Federal Register Volume 81, Number 50 (Tuesday, March 15, 2016)]
[Notices]
[Pages 13798-13801]
[FR Doc No: 2016-05718]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-D-1814]

Bacterial Risk Control Strategies for Blood Collection
Establishments and Transfusion Services To Enhance the Safety and
Availability of Platelets for Transfusion; Draft Guidance for Industry;
Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of availability.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing
the availability of a draft document entitled ``Bacterial Risk Control
Strategies for Blood Collection Establishments and Transfusion Services
to Enhance the Safety and Availability of Platelets for Transfusion;
Draft Guidance for Industry.'' The draft guidance document provides
blood collection establishments and transfusion services with
recommendations to control the risk of bacterial contamination of room
temperature stored platelets intended for transfusion through the
implementation of pathogen reduction technology (PRT) or bacterial
testing. The draft guidance also provides recommendations for the use
of secondary testing of platelets as the basis to extend the dating
period of platelets, when appropriately labeled bacterial detection
devices and storage containers are used. The draft guidance replaces
the draft guidance entitled ``Bacterial Detection Testing by Blood
Collection Establishments and Transfusion Services to Enhance the
Safety and Availability of Platelets for Transfusion,'' dated December
2014. The draft guidance, when finalized, is intended to supersede the
recommendation in section VII.A.2, in regard to bacterial contamination
testing in the document entitled ``Guidance for Industry and FDA Review
Staff: Collection of Platelets by Automated Methods'' dated December
2007.

DATES: Although you can comment on any guidance at any time (see 21 CFR
10.115(g)(5)), to ensure that the Agency considers your comment on this
draft guidance before it begins work on the final version of the
guidance, submit either electronic or written comments on the draft
guidance by June 13, 2016. Submit either electronic or written comments
on the collection of information by May 16, 2016.

ADDRESSES: You may submit comments as follows:

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2014-D-1814 for ``Bacterial Risk Control Strategies for Blood
Collection Establishments and Transfusion Services to Enhance the
Safety and Availability of Platelets for Transfusion; Draft Guidance
for Industry.'' Received comments will be placed in the docket and,
except for those submitted as ``Confidential Submissions,'' publicly
viewable at http://www.regulations.gov or at the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
    Submit written requests for single copies of the draft guidance to
the Office of Communication, Outreach and Development, Center for
Biologics Evaluation and Research (CBER), Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 71, Rm. 3128, Silver Spring, MD 20993-
0002. Send one self-addressed adhesive label to assist the office in
processing your requests. The draft guidance may also be obtained by
mail by calling CBER at 1-800-835-4709 or<PHONE_NUMBER>. See
SUPPLEMENTARY INFORMATION section for electronic access to the draft
guidance document.

FOR FURTHER INFORMATION CONTACT: Information Collection Requirements:
FDA PRA Staff, Office of Operations, Food and Drug Administration, 8455
Colesville Rd., COLE-14526, Silver Spring, MD 20993-0002,
<EMAIL_ADDRESS>    Guidance Document: Jonathan McKnight, Center for Biologics
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 71, Rm. 7301, Silver Spring, MD 20993-0002, 240-
402-7911.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a draft document entitled
``Bacterial Risk Control Strategies for Blood Collection Establishments
and Transfusion Services to Enhance the Safety and Availability of
Platelets for Transfusion; Draft Guidance for Industry.'' Platelets are
associated with a higher risk of sepsis and are related to more
fatalities than any other transfusable blood component. The risk of
bacterial contamination of platelets is a leading risk of infection
from blood transfusion. This risk has persisted despite numerous
interventions including the introduction, in the last decade, of
analytically sensitive culture-based bacterial detection methods, which
are widely used to test platelets prior to their release from blood
collection establishments to transfusion services.
    The draft guidance provides blood collection establishments and
transfusion services with recommendations to control the risk of
bacterial contamination of room temperature stored platelets intended
for transfusion through the implementation of PRT or bacterial testing.
PRT is performed shortly after platelet collection by blood collection
establishments. Bacterial testing encompasses primary testing of
platelets by blood collection establishments and subsequent secondary
testing prior to transfusion primarily by transfusion services. The
draft guidance also provides recommendations for the use of secondary
testing of platelets as the basis to extend the dating period of
platelets, when appropriately labeled bacterial detection devices and
storage containers are used. Additionally, the draft guidance provides
recommendations to licensed blood establishments for submitting
biologics license application supplements to

include bacterial testing of platelet components. The guidance informs
transfusion services that are currently exempt from registration and
blood product listing that if they choose to perform secondary testing
of platelets to extend the dating period, they must register with FDA
and list the blood products they manufacture.
    The draft guidance applies to all platelet products, including
platelets manufactured from Whole Blood (Whole Blood Derived (WBD)
platelets), platelets collected by automated methods from a single
donor (apheresis platelets), pooled platelets, and platelets stored in
additive solutions.
    The draft guidance is being issued consistent with FDA's good
guidance practices regulation (21 CFR 10.115). The draft guidance, when
finalized, will represent the current thinking of FDA on bacterial risk
control strategies for blood collection establishments and transfusion
services to enhance the safety and availability of platelets for
transfusion. It does not establish any rights for any person and is not
binding on FDA or the public. You can use an alternative if it
satisfies the requirements of the applicable statutes and regulations.

II. Paperwork Reduction Act of 1995

    Under the PRA (44 U.S.C. 3501-3520), Federal Agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. ``Collection of
information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and
includes Agency requests or requirements that members of the public
submit reports, keep records, or provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A)) requires
Federal Agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, before submitting
the collection to OMB for approval. To comply with this requirement,
FDA is publishing notice of the proposed collection of information set
forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.
    Title: Bacterial Risk Control Strategies for Blood Collection
Establishments and Transfusion Services to Enhance the Safety and
Availability of Platelets for Transfusion.
    Description: We have identified the following recommendations in
the draft guidance document as collections of information. In section
VI, the draft guidance recommends that blood collection establishments
have in place measures to promptly alert the transfusion services in
the event that a distributed platelet product is subsequently
identified as positive for bacterial contamination. In section X.A.2,
the draft guidance recommends that following secondary testing,
labeling on the container label or a tie-tag, should relay the
following information: (1) Type of bacterial detection test performed
(rapid or culture) and (2) the date and time the bacterial detection
test was performed.
    Description of Respondents: The third-party disclosure
recommendations described in the draft guidance affect blood collection
establishments and transfusion services that collect and manufacture
platelet products for transfusion, including WBD platelets, apheresis
platelets, pooled platelets, and platelets stored in additive
solutions.
    Burden Estimate: The Agency believes the information collection
provision for blood collection establishments in section VI does not
create a new burden for respondents and is part of usual and customary
business practice. Blood collection establishments currently have in
place standard operating procedures for notifying consignees
(transfusion services) if a distributed platelet product has
subsequently tested positive for bacterial contamination.
    In section X.A.2, the draft guidance recommends that following
secondary testing, establishments should maintain a labeling process
that relays certain information and is integral to the container (e.g.,
on the container label or an attached tie-tag) and label accordingly.
FDA estimates the burden of this collection of information as follows:

                                               Table 1--Estimated Annual Third-Party Disclosure Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                      Number of
                    Activity                         Number of     disclosures per    Total annual     Average burden  per disclosure      Total hours
                                                    respondents       respondent      disclosures
--------------------------------------------------------------------------------------------------------------------------------------------------------
Section X.A.2: Following secondary testing,                 2480              403        1,000,000   .05 (3 minutes)...................          50,000
 maintain a labeling process that relays certain
 information and is integral to the container
 (e.g., on the container label or an attached
 tie-tag) and label accordingly.
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.

    Table 1 provides an estimate of the annual third-party disclosure
burden for the information to be submitted in accordance with the draft
guidance. Based on FDA data and information submitted by industry, FDA
believes that there are approximately 2 million platelet transfusions
per year. The recommendation for labeling following secondary testing
applies to approximately 4,960 transfusion services in the Unites
States. We estimate that about 50 percent of all platelets will be
pathogen-reduced and 50 percent will be cultured. Therefore, to
estimate the annual third-party disclosure burden in table 1, we assume
that approximately one-half of the transfusion services will label one-
half of the total platelets intended for transfusion in the United
States following secondary testing. The average burden disclosure for
transfusion services to implement the recommendation in table 1 is
based on FDA's experience and industry information.
    This draft guidance also refers to previously approved collections
of information found in FDA regulations. The collections of information
in 21 CFR 601.12 and 610.60 have been approved under OMB control number

0910-0338; the collections of information in 21 CFR 606.65, 606.100,
606.120, 606.121, 606.122, and have been approved under OMB control
number 0910-0116; and the collections of information in 21 CFR part 607
have been approved under OMB control number 0910-0052.
    To ensure that comments on information collection are received, OMB
recommends that written comments be faxed to the Office of Information
and Regulatory Affairs, OMB (see ADDRESSES). All comments should be
identified with the title of the information collection.
    In compliance with the PRA (44 U.S.C. 3407(d)), the Agency has
submitted the information collection provisions of this document to OMB
for review. These requirements will not be effective until FDA obtains
OMB approval. FDA will publish a notice concerning OMB approval of
these requirements in the Federal Register.

III. Electronic Access

    Persons with access to the Internet may obtain the draft guidance
at either http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm or http://www.regulations.gov.

    Dated: March 9, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-05718 Filed 3-14-16; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register: February 17, 2006 (Volume 71, Number 33)]
[Notices]
[Page 8572]
[DOCID:fr17fe06-46]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP06-217-000]

Trans-Union Interstate Pipeline, L.P.; Notice of Proposed Changes
in FERC Gas Tariff

February 10, 2006.
    Take notice that on February 7, 2006, Trans-Union Interstate
Pipeline, L.P. (Trans-Union), tendered for filing its FERC Gas Tariff,
Original Volume No. 1, to become effective on February 7, 2006. Trans-
Union states that the proposed tariff sheets include a rate decrease
for Trans-Union's firm and interruptible transportation services, based
on a 12-month period ending October 31, 2005, as adjusted.
    Trans-Union further states that it has served copies of its filing
on all affected customers and all interested state regulatory
commissions.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211 and 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed in accordance with the provisions of
Section 154.210 of the Commission's regulations (18 CFR 154.210).
Anyone filing an intervention or protest must serve a copy of that
document on the Applicant. Anyone filing an intervention or protest on
or before the intervention or protest date need not serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Magalie R. Salas,
Secretary.
 [FR Doc. E6-2273 Filed 2-16-06; 8:45 am]

BILLING CODE 6717-01-P